Sex: U
Vaccine: DTAP, DTAPIPVHIB, HIBV, IPV, MNQ, TD, TDAP
Symptoms: Product storage error
Clinical narrative: The temperature range was from 37.5F to 48.2F; Initial information received on 03-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient with unknown demographics whos temperature range was from 37.5f to 48.2f while receiving vaccines DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL], MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA], HIB (PRP/T) VACCINE [ActHIB], DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect IPV (VERO) lot U1C571M via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5774BA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ414AAA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect HIB (PRP/T) VACCINE lot UJ583ABA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U7191AA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U6900AA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT lot C5779AA via unknown route in unknown administration site.  On 03-JAN-2022 the patient developed a non-serious the temperature range was from 37.5f to 48.2f (product storage error) (unknown latency) following the administration of IPV (VERO), , TETANUS AND ACELLULAR PERTUSSIS VACCINE (DAPTACEL), DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL), HAEMOPHILUS TYPE B (HIB) VACCINE (ActHIB), MENINGOCOCCAL VACCINE (MENACTRA), DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) and DIPHTHERIA AND TETANUS TOXOIDS (TENIVAC) was not applicable.  It was not reported if the patient received a corrective treatment for the event (The temperature range was from 37.5F to 48.2F).  At time of reporting, the outcome was Unknown for the event the temperature range was from 37.5f to 48.2f.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.